Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Merck & Co. selects lead from new series of phosphodiesterase 10A inhibitors

April 18, 2012

PRINT nanofabrication allows precision synthesis of therapeutic particles

April 18, 2012

New Exp1 inhibitors show promise in a number of in vitro and in vivo cancer studies

April 18, 2012

New potential pancreatic cancer biomarker identified at H. Lee Moffitt Center

April 17, 2012

Scientists describe analgesic effects of novel cannabinoid CB2 receptor agonists

April 17, 2012

Regeneron Pharmaceuticals generates new anticancer antibody

April 17, 2012

Two new promising oncology programs presented

April 17, 2012

Multitargeted antimitotic drug achieves tumor regression in vivo

April 17, 2012

Preclinical data support clinical testing of AVEO antibody

April 17, 2012

Novel Astellas histone deacetylase inhibitor has encouraging pharmacokinetics

April 16, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...